Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension

Ola Granström,1 Lars-Åke Levin,2 Martin Henriksson11AstraZeneca Nordic, Södertälje, 2Center for Medical Technology Assessment, Linköping University, Linköping, SwedenBackground: Although angiotensin receptor blockers have...

Full description

Bibliographic Details
Main Authors: Granström O, Levin LA, Henriksson M
Format: Article
Language:English
Published: Dove Medical Press 2012-11-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/cost-effectiveness-of-candesartan-versus-losartan-in-the-primary-preve-a11405

Internet

http://www.dovepress.com/cost-effectiveness-of-candesartan-versus-losartan-in-the-primary-preve-a11405

Similar Items